Gerresheimer’s (GXI) “Neutral” Rating Reiterated at DZ Bank

DZ Bank reaffirmed their neutral rating on shares of Gerresheimer (ETR:GXI) in a report published on Thursday, Borsen Zeitung reports.

Several other brokerages also recently weighed in on GXI. Deutsche Bank cut their price target on shares of from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating on the stock in a report on Monday, June 24th. JPMorgan Chase & Co. set a GBX 3,200 ($41.81) price target on shares of Diageo and gave the stock a neutral rating in a report on Wednesday. Kepler Capital Markets set a €19.00 ($22.09) price target on shares of Rhoen Klinikum and gave the stock a sell rating in a report on Thursday, April 11th. HSBC cut their price target on shares of WPP from GBX 1,000 ($13.07) to GBX 970 ($12.67) and set a hold rating on the stock in a report on Thursday, July 4th. Finally, Credit Suisse Group reiterated a hold rating on shares of FactSet Research Systems in a report on Monday, July 8th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. Gerresheimer currently has an average rating of Hold and an average target price of €69.17 ($80.43).

Shares of ETR:GXI opened at €73.65 ($85.64) on Thursday. Gerresheimer has a twelve month low of €51.10 ($59.42) and a twelve month high of €80.25 ($93.31). The stock has a 50 day simple moving average of €65.08. The company has a current ratio of 0.78, a quick ratio of 0.51 and a debt-to-equity ratio of 68.19. The firm has a market cap of $2.31 billion and a P/E ratio of 12.90.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: Equal Weight Rating

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.